IMV Inc.

Symbol: IMV




Market price today

  • -42.2605

    P/E Ratio

  • 2.7405

    PEG Ratio

  • 9.63M

    MRK Cap

  • 0.00%

    DIV Yield

IMV Inc. (IMV) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Andrew Hall M.Sc.
Full-time employees:63
Address:130 Eileen Stubbs Avenue

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

General Outlook

In simple terms, IMV Inc. has 11.712 M shares that people are buying and selling right now.

Return on Investments

The company's asset efficiency, represented by a robust -0.511% return, is a testament to IMV Inc.'s adeptness in optimizing resource deployment. IMV Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 2.482%. Furthermore, the proficiency of IMV Inc. in capital utilization is underscored by a remarkable -0.833% return on capital employed.

Stock Prices

IMV Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.8225, while its low point bottomed out at $0.8225. This variance in figures offers investors a lucid insight into the roller-coaster ride that is IMV Inc.'s stock market.

Liquidity Ratios

Analyzing IMV liquidity ratios reveals its financial health of the firm. The current ratio of 292.87% gauges short-term asset coverage for liabilities. The quick ratio (245.73%) assesses immediate liquidity, while the cash ratio (225.30%) indicates cash reserves.

Current Ratio292.87%
Quick Ratio245.73%
Cash Ratio225.30%

Profitability Ratios

The effective tax rate stands at 8.72%, revealing its tax efficiency. The net income per EBT, 91.28%, and the EBT per EBIT, 96.12%, provide insights into its earnings hierarchy.

Effective Tax Rate8.72%
Net Income per EBT91.28%
EBT per EBIT96.12%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.93, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding246

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.02, and free cash flow per share, -0.02, depict cash generation on a per-share basis. The cash per share value, 0.03, showcases liquidity position.

Operating Cash Flow per Share-0.02
Free Cash Flow per Share-0.02
Cash per Share0.03
Free Cash Flow to Operating Cash Flow Ratio1.03
Cash Flow Coverage Ratio-0.57
Short Term Coverage Ratio-44.99
Capital Expenditure Coverage Ratio-37.70
Dividend Paid and Capex Coverage Ratio-37.70

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 92.18%, highlights its total liabilities relative to assets. With a debt-equity ratio of -4.38, we discern the balance between debt and equity financing. The long-term debt to capitalization, 130.11%, and total debt to capitalization, 129.61%, ratios shed light on its capital structure. An interest coverage of -25.77 indicates its ability to manage interest expenses.

Debt Ratio92.18%
Debt Equity Ratio-4.38
Long Term Debt to Capitalization130.11%
Total Debt to Capitalization129.61%
Interest Coverage-25.77
Cash Flow to Debt Ratio-0.57
Company Equity Multiplier-4.75

Per Share Data

Net income per share, -4.61, reflects the portion of profit attributed to each share. The book value per share, -0.79, represents the net asset value distributed per share, while the tangible book value per share, -0.79, excludes intangible assets.

Net Income Per Share-4.61
Book Value Per Share-0.79
Tangible Book Value Per Share-0.79
Shareholders Equity Per Share-0.79
Interest Debt Per Share3.52
Capex Per Share-0.13

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 27,948,595.65, captures the company's total value, considering both debt and equity. Income quality, 0.88, assesses the reliability of reported earnings.

Enterprise Value27,948,595.65
Income Quality0.88
Capex to Operating Cash Flow3.22%
Capex to Depreciation-107.19%
Graham Number9.06
Return on Tangible Assets-122.79%
Graham Net Net-1.83
Working Capital18,168,000
Tangible Asset Value-6,602,000
Net Current Asset Value-10,362,000
Invested Capital-4
Average Receivables1,831,000
Average Payables3,907,000

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -102.60, and the price to book ratio, -102.60, reflect the market's valuation relative to the company's book value. Ratios like price to free cash flows, -0.57, and price to operating cash flows, -41.03, gauge market valuation against cash flow metrics.

Price Book Value Ratio-102.60
Price to Book Ratio-102.60
Price Cash Flow Ratio-41.03
Price Earnings to Growth Ratio2.74
Enterprise Value Multiple-0.11
Price Fair Value-102.60
Price to Operating Cash Flow Ratio-41.03
Price to Free Cash Flows Ratio-0.57
Price to Tangible Book Ratio-3.07
Enterprise Value Over EBITDA-0.73
EV to Operating Cash Flow-0.84
Earnings Yield-189.85%
Free Cash Flow Yield-170.02%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of IMV Inc. (IMV) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -42.261 in 2024.

What is the ticker symbol of IMV Inc. stock?

The ticker symbol of IMV Inc. stock is IMV.

What is company IPO date?

IPO date of IMV Inc. is 2007-10-24.

What is company current share price?

Current share price is 0.823 USD.

What is stock market cap today?

The market cap of stock today is 9632791.000.

What is PEG ratio in 2024?

The current 2.741 is 2.741 in 2024.

What is the number of employees in 2024?

In 2024 the company has 63.